1.

Synthèse des résultats du processus HEPA-PAT en Belgique francophone et germanophone

2.

Synthèse des résultats du processus HEPA-PAT en Belgique francophone et germanophone

3.

Synthèse des résultats du processus HEPA-PAT en Belgique francophone et germanophone

1.

Five years of experience for the promotion of a better nutritional environment in schools : The programme "Je mange bien à l'école" (I eat well at school) an innovatie project deve...

2.

Five years of experience for the promotion of a better nutritional environment in schools : The programme "Je mange bien à l'école" (I eat well at school) an innovatie project deve...

3.

Five years of experience for the promotion of a better nutritional environment in schools : The programme "Je mange bien à l'école" (I eat well at school) an innovatie project deve...

4.

Five years of experience for the promotion of a better nutritional environment in schools : The programme "Je mange bien à l'école" (I eat well at school) an innovatie project deve...

5.

Five years of experience for the promotion of a better nutritional environment in schools : The programme "Je mange bien à l'école" (I eat well at school) an innovatie project deve...

6.

Five years of experience for the promotion of a better nutritional environment in schools : The programme "Je mange bien à l'école" (I eat well at school) an innovatie project deve...

7.

Five years of experience for the promotion of a better nutritional environment in schools : The programme "Je mange bien à l'école" (I eat well at school) an innovatie project deve...

8.

Five years of experience for the promotion of a better nutritional environment in schools : The programme "Je mange bien à l'école" (I eat well at school) an innovatie project deve...

9.

Five years of experience for the promotion of a better nutritional environment in schools : The programme "Je mange bien à l'école" (I eat well at school) an innovatie project deve...

1.

Towards a Better Quantification of Cyanotoxins in Fruits and Vegetables: Validation and Application of an UHPLC-MS/MS-Based Method on Belgian Products

2.

Towards a Better Quantification of Cyanotoxins in Fruits and Vegetables: Validation and Application of an UHPLC-MS/MS-Based Method on Belgian Products

3.

Towards a Better Quantification of Cyanotoxins in Fruits and Vegetables: Validation and Application of an UHPLC-MS/MS-Based Method on Belgian Products

4.

Towards a Better Quantification of Cyanotoxins in Fruits and Vegetables: Validation and Application of an UHPLC-MS/MS-Based Method on Belgian Products

5.

Towards a Better Quantification of Cyanotoxins in Fruits and Vegetables: Validation and Application of an UHPLC-MS/MS-Based Method on Belgian Products

6.

Towards a Better Quantification of Cyanotoxins in Fruits and Vegetables: Validation and Application of an UHPLC-MS/MS-Based Method on Belgian Products

1.

Dietary intake of PCDD/Fs and dioxin-like PCBs of the Belgian Population

2.

Dietary intake of PCDD/Fs and dioxin-like PCBs of the Belgian Population

3.

Dietary intake of PCDD/Fs and dioxin-like PCBs of the Belgian Population

4.

Dietary intake of PCDD/Fs and dioxin-like PCBs of the Belgian Population

5.

Dietary intake of PCDD/Fs and dioxin-like PCBs of the Belgian Population

6.

Dietary intake of PCDD/Fs and dioxin-like PCBs of the Belgian Population

1.

Strategies for MSD prevention - A new model proposed by a Belgian task force

2.

Strategies for MSD prevention - A new model proposed by a Belgian task force

3.

Strategies for MSD prevention - A new model proposed by a Belgian task force

4.

Strategies for MSD prevention - A new model proposed by a Belgian task force

5.

Strategies for MSD prevention - A new model proposed by a Belgian task force

6.

Strategies for MSD prevention - A new model proposed by a Belgian task force

1.

Transition between peritoneal dialysis and home hemodialysis in Belgium and France in the RDPLF ; Transition entre dialyse péritonéale et hémodialyse à domicile en Belgique et Fran...

2.

Transition between peritoneal dialysis and home hemodialysis in Belgium and France in the RDPLF ; Transition entre dialyse péritonéale et hémodialyse à domicile en Belgique et Fran...

3.

Transition between peritoneal dialysis and home hemodialysis in Belgium and France in the RDPLF ; Transition entre dialyse péritonéale et hémodialyse à domicile en Belgique et Fran...

4.

Transition between peritoneal dialysis and home hemodialysis in Belgium and France in the RDPLF ; Transition entre dialyse péritonéale et hémodialyse à domicile en Belgique et Fran...

5.

Transition between peritoneal dialysis and home hemodialysis in Belgium and France in the RDPLF ; Transition entre dialyse péritonéale et hémodialyse à domicile en Belgique et Fran...

6.

Transition between peritoneal dialysis and home hemodialysis in Belgium and France in the RDPLF ; Transition entre dialyse péritonéale et hémodialyse à domicile en Belgique et Fran...

7.

Transition between peritoneal dialysis and home hemodialysis in Belgium and France in the RDPLF ; Transition entre dialyse péritonéale et hémodialyse à domicile en Belgique et Fran...

8.

Transition between peritoneal dialysis and home hemodialysis in Belgium and France in the RDPLF ; Transition entre dialyse péritonéale et hémodialyse à domicile en Belgique et Fran...

9.

Transition between peritoneal dialysis and home hemodialysis in Belgium and France in the RDPLF ; Transition entre dialyse péritonéale et hémodialyse à domicile en Belgique et Fran...

1.

Characterization of Group B Streptococcus strains isolated from neonatal invasive diseases in Belgium, 2015.

2.

Characterization of Group B Streptococcus strains isolated from neonatal invasive diseases in Belgium, 2015.

3.

Characterization of Group B Streptococcus strains isolated from neonatal invasive diseases in Belgium, 2015.

4.

Characterization of Group B Streptococcus strains isolated from neonatal invasive diseases in Belgium, 2015.

5.

Characterization of Group B Streptococcus strains isolated from neonatal invasive diseases in Belgium, 2015.

6.

Characterization of Group B Streptococcus strains isolated from neonatal invasive diseases in Belgium, 2015.

7.

Characterization of Group B Streptococcus strains isolated from neonatal invasive diseases in Belgium, 2015.

8.

Characterization of Group B Streptococcus strains isolated from neonatal invasive diseases in Belgium, 2015.

9.

Characterization of Group B Streptococcus strains isolated from neonatal invasive diseases in Belgium, 2015.

1.

Prevalence and incidence of antibodies against SARS-CoV-2 among primary healthcare providers in Belgium during 1 year of the COVID-19 epidemic: prospective cohort study protocol.

2.

Prevalence and incidence of antibodies against SARS-CoV-2 among primary healthcare providers in Belgium during 1 year of the COVID-19 epidemic: prospective cohort study protocol.

3.

Prevalence and incidence of antibodies against SARS-CoV-2 among primary healthcare providers in Belgium during 1 year of the COVID-19 epidemic: prospective cohort study protocol.

4.

Prevalence and incidence of antibodies against SARS-CoV-2 among primary healthcare providers in Belgium during 1 year of the COVID-19 epidemic: prospective cohort study protocol.

5.

Prevalence and incidence of antibodies against SARS-CoV-2 among primary healthcare providers in Belgium during 1 year of the COVID-19 epidemic: prospective cohort study protocol.

6.

Prevalence and incidence of antibodies against SARS-CoV-2 among primary healthcare providers in Belgium during 1 year of the COVID-19 epidemic: prospective cohort study protocol.

7.

Prevalence and incidence of antibodies against SARS-CoV-2 among primary healthcare providers in Belgium during 1 year of the COVID-19 epidemic: prospective cohort study protocol.

8.

Prevalence and incidence of antibodies against SARS-CoV-2 among primary healthcare providers in Belgium during 1 year of the COVID-19 epidemic: prospective cohort study protocol.

9.

Prevalence and incidence of antibodies against SARS-CoV-2 among primary healthcare providers in Belgium during 1 year of the COVID-19 epidemic: prospective cohort study protocol.

1.

Evaluating Large-Scale Integrated Care Projects: The Development of a Protocol for a Mixed Methods Realist Evaluation Study in Belgium

2.

Evaluating Large-Scale Integrated Care Projects: The Development of a Protocol for a Mixed Methods Realist Evaluation Study in Belgium

3.

Evaluating Large-Scale Integrated Care Projects: The Development of a Protocol for a Mixed Methods Realist Evaluation Study in Belgium

4.

Evaluating Large-Scale Integrated Care Projects: The Development of a Protocol for a Mixed Methods Realist Evaluation Study in Belgium

1.

The Vienna self-assessment questionnaire: a usable tool towards more health-literate hospitals? Explorative case studies in three hospitals in Belgium

2.

The Vienna self-assessment questionnaire: a usable tool towards more health-literate hospitals? Explorative case studies in three hospitals in Belgium

3.

The Vienna self-assessment questionnaire: a usable tool towards more health-literate hospitals? Explorative case studies in three hospitals in Belgium

4.

The Vienna self-assessment questionnaire: a usable tool towards more health-literate hospitals? Explorative case studies in three hospitals in Belgium